Table 2 Striatal ¹¹C-raclopride (RAC) binding potential of subject Nos 1 and 2 and Huntington’s disease controls

Subject	Region	RAC binding potential
		Postoperative months
		−6	6	18	24	30
S1	R striatum	1.72	2.06	–	–	1.71
	L striatum	1.58	1.99	–	–	1.76
S2	R striatum	1.09	0.96	0.87	–	–
	L striatum	1.11	0.88	0.85	–	–
C	Mean striatum (SD)	1.42 (0.47 )	–	1.25 (0.33)	–	1.19 (0.32)

Control values = mean (SD). Control values were inserted where available.
C, Huntington’s disease controls; S1, subject No 1; S2, subject No 2.